No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Gilead Sciences: Berger to Succeed Merdad Parsey on Jan. 2
Gilead Sciences Appoints Dietmar Berger, MD, PhD, as Chief Medical Officer
Express News | Gilead Sciences Appoints Dietmar Berger, Md, Phd, as Chief Medical Officer
Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing
CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal
Is Gilead Sciences (GILD) Stock Undervalued Right Now?